Richard H Carmona
CIK 1389349 · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AAXN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
OAKLAND, CA 94612
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HLF | Director | 83,645 | $15.28 | $1.28M | -$555.0K | 16 | 2026-05-12 |
| MCK | Director | — | $1060.84 | — | $0 | 4 | 2024-08-01 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 157,369 | $0.04 | $7.0K | $0 | 4 | 2023-12-20 |
| CLX | Director | — | $99.96 | — | $0 | 15 | 2022-01-04 |
| AXON | Director | 19,162 | $313.00 | $6.00M | $0 | 1 | 2021-06-01 |
| AXON ENTERPRISE, INC. (AAXN) Delisted | Director | 17,728 | — | — | -$9.22M | 9 | 2020-06-02 |
Recent Filings · Page 3 of 6
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-13 | AXON ENTERPRISE, INC. (AAXN) Delisted | Mixed | — | -$3.64M | EDGAR |
| 2020-05-13 | HLF | Grant (A) | +3,407 | $0 | EDGAR |
| 2020-03-05 | AXON ENTERPRISE, INC. (AAXN) Delisted | Sell (S) | −29,487 | -$2.34M | EDGAR |
| 2020-01-03 | CLX | Grant (A) | — | $0 | EDGAR |
| 2019-06-03 | AXON ENTERPRISE, INC. (AAXN) Delisted | Mixed | −25,539 | -$1.74M | EDGAR |
| 2019-05-08 | HLF | Grant (A) | +2,689 | $0 | EDGAR |
| 2019-03-14 | AXON ENTERPRISE, INC. (AAXN) Delisted | Mixed | — | -$1.04M | EDGAR |
| 2019-01-03 | CLX | Grant (A) | — | $0 | EDGAR |
| 2018-11-01 | AXON ENTERPRISE, INC. (AAXN) Delisted | Grant (A) | +1,000 | $61.7K | EDGAR |
| 2018-05-24 | AXON ENTERPRISE, INC. (AAXN) Delisted | Grant (A) | +2,577 | $160.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.